Wolverine Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,315
Closed -$219K 1857
2025
Q3
$219K Sell
7,315
-134
-2% -$4.47K ﹤0.01% 1006
2025
Q2
$221K Sell
7,449
-1,226
-14% -$35.3K ﹤0.01% 1012
2025
Q1
$265K Sell
8,675
-19,091
-69% -$643K ﹤0.01% 969
2024
Q4
$1.1M Hold
27,766
0.01% 667
2024
Q3
$1.08M Buy
27,766
+1,800
+7% +$72.8K 0.01% 679
2024
Q2
$1.09M Buy
+25,966
New +$886K 0.01% 646

Other funds holding SRDX

Wolverine Asset Management's SRDX Position: Q4 2025 in Review

Wolverine Asset Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 7,315 shares — an estimated $219K sold.

Wolverine Asset Management first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $1.1M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Wolverine Asset Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 7,315 Surmodics shares in Q4 2025, an estimated $219K.
  • Wolverine Asset Management first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
  • Wolverine Asset Management's Surmodics position peaked at $1.1M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.